VeroScience
Veroscience is dedicated to understanding and applying nature’s genius to successfully treat human disease and improve the human condition. The company focuses on innovative technologies and therapies, including Circadian Neuroendocrine Resetting Therapy (CNRT) and Photo Immuno-Resetting Therapy for the treatment of cancer, with a mission to develop effective treatments for metabolic diseases, immunological disorders, and other therapeutic areas.
Industries
Nr. of Employees
small (1-50)
VeroScience
Patents
Products
FDA-approved dopamine D2 receptor agonist (type 2 diabetes)
An FDA-approved therapeutic agent acting as a dopamine D2 receptor agonist indicated for treatment of type 2 diabetes.
Oncology development candidate (pancreatic cancer)
Therapeutic candidate in development for pancreatic cancer within the company's pipeline.
Pediatric type 2 diabetes therapeutic program
Development program addressing pediatric type 2 diabetes patients.
FDA-approved dopamine D2 receptor agonist (type 2 diabetes)
An FDA-approved therapeutic agent acting as a dopamine D2 receptor agonist indicated for treatment of type 2 diabetes.
Oncology development candidate (pancreatic cancer)
Therapeutic candidate in development for pancreatic cancer within the company's pipeline.
Pediatric type 2 diabetes therapeutic program
Development program addressing pediatric type 2 diabetes patients.
Services
In vivo rodent model studies and metabolic phenotyping to evaluate disease mechanisms and candidate effects.
Planning and conducting clinical studies for therapeutic candidates to support regulatory submissions.
Experimental characterization of drug mechanisms and pharmacological profiling to support development decisions.
Regulatory filing experience and management of U.S. patent assets related to therapeutic products.
In vivo rodent model studies and metabolic phenotyping to evaluate disease mechanisms and candidate effects.
Planning and conducting clinical studies for therapeutic candidates to support regulatory submissions.
Experimental characterization of drug mechanisms and pharmacological profiling to support development decisions.
Regulatory filing experience and management of U.S. patent assets related to therapeutic products.
Expertise Areas
- Circadian biology and neuroendocrine modulation
- Preclinical in vivo models and metabolic phenotyping
- Clinical trial management for metabolic disease
- Molecular biology and neuropharmacology
Key Technologies
- Circadian neuroendocrine resetting therapy
- Photodynamic therapy for oncology
- Dopamine D2 receptor agonist pharmacology
- Rodent lesion models (SCN/dopaminergic)